Tag Archives: KV Pharamceuticals. March of Dimes

How I would have handled the “compounding issue” with 17 hydroxyprogesterone

Both The March of Dimes and The American Congress of OB/GYN  (and apparently a few other medical professional societies) supported KV Pharmaceuticals application to the FDA to be the sole manufacturer of 17 Alpha Hydroxyprogesterone caproate (17P), the hormone that … Continue reading

Posted in Uncategorized | Tagged , , | 1 Comment